🔎 Trials Near Me

Home › Alpha-1 Antitrypsin Deficiency › Arizona

Alpha-1 Antitrypsin Deficiency clinical trials in Arizona

3 studies for Alpha-1 Antitrypsin Deficiency are looking for participants at sites in Arizona.

Cities in Arizona

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

  • GC2501 Study Site 102, Phoenix
  • GC2501 Study Site 107, Scottsdale
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Aug 11, 2026 · NCT07555483

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

  • St. Joseph's Hospital and Medical Center, Phoenix
  • Mayo Clinic, Phoenix
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated May 13, 2026 · NCT05677971

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

  • St Joseph's Hospital and Medical Center, Phoenix
  • Mayo Clinic - PPDS, Phoenix
  • University of Arizona Thomas D. Boyer Liver Institute, Tucson
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Mar 5, 2026 · NCT06165341

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.